| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
C-X3-C motif chemokine ligand 1 | 0.478 | 0.808 | 0.61 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2009 | 2011 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2009 | 2013 | ||||||||
|
argininosuccinate synthase 1 | 0.523 | 0.731 | 1.5E-09 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2000 | 2011 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2011 | 2017 | ||||||||
|
ATP binding cassette subfamily C member 8 | 0.474 | 0.846 | 8.0E-24 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2007 | 2009 | ||||||||
|
von Willebrand factor | 0.408 | 0.885 | 3.2E-25 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 1989 | 2008 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 1987 | 2018 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2004 | 2017 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2006 | 2011 | ||||||||
|
phospholipase A2 group VII | 0.537 | 0.769 | 5.3E-22 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2000 | 2012 | ||||||||
|
thromboxane A synthase 1 | 0.619 | 0.615 | 1.4E-20 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
prostaglandin E receptor 4 | 0.558 | 0.731 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
solute carrier family 22 member 2 | 0.572 | 0.769 | 2.0E-12 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
caspase 9 | 0.458 | 0.808 | 7.4E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
proprotein convertase subtilisin/kexin type 1 | 0.548 | 0.615 | 2.7E-09 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
phosphoenolpyruvate carboxykinase 2, mitochondrial | 0.653 | 0.423 | 1.7E-23 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
ATP binding cassette subfamily B member 11 | 0.566 | 0.654 | 1.6E-12 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
signal transducer and activator of transcription 5B | 0.442 | 0.808 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
actin alpha cardiac muscle 1 | 0.610 | 0.538 | 0.74 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
TIMP metallopeptidase inhibitor 3 | 0.445 | 0.923 | 0.63 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 |